1. Effect of AKT silence on malignant biological behavior of renal cell carcinoma cells
   Zuan Li et al, 2022, BMC Urology CrossRef
2. Expressions of ezrin, ERK, STAT3, and AKT in tongue cancer and association with tumor characteristics and patient survival
   Masaharu Noi et al, 2020, Clinical and Experimental Dental Research CrossRef
3. CircPDE5A-encoded novel regulator of the PI3K/AKT pathway inhibits esophageal squamous cell carcinoma progression by promoting USP14-mediated de-ubiquitination of PIK3IP1
   Kai Lei et al, 2024, Journal of Experimental & Clinical Cancer Research CrossRef
4. Biological and clinical relevance of metastasis‐associated long noncoding RNAs in esophageal squamous cell carcinoma: A systematic review
   Atefeh Talebi et al, 2020, Journal of Cellular Physiology CrossRef
5. PI3K/Akt signalling pathway-associated long noncoding RNA signature predicts the prognosis of laryngeal cancer patients
   Qian Nie et al, 2023, Scientific Reports CrossRef
6. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma
   Guiqin Hou et al, 2018, Biomedicine & Pharmacotherapy CrossRef
7. DNA methylation data‐based prognosis‐subtype distinctions in patients with esophageal carcinoma by bioinformatic studies
   Hui Chen et al, 2021, Journal of Cellular Physiology CrossRef
8. Quantifying and correcting slide-to-slide variation in multiplexed immunofluorescence images
   Coleman R Harris et al, 2022, Bioinformatics CrossRef
9. MicroRNA-126 regulates the phosphatidylinositol-3 kinase (PI3K)/protein kinase B (AKT) pathway in SLK cells in vitro and the expression of its pathway members in Kaposi's sarcoma tissue
   Gaihui Lu et al, 2018, Medicine CrossRef
10. Biological Role of AKT and Regulation of AKT Signaling Pathway by Thymoquinone: Perspectives in Cancer Therapeutics
    Md. Junaid et al, 2021, Mini-Reviews in Medicinal Chemistry CrossRef
11. AKT as a Therapeutic Target for Cancer
    Mengqiu Song et al, 2019, Cancer Research CrossRef
12. Silencing of KNTC1 inhibits hepatocellular carcinoma cells progression via suppressing PI3K/Akt pathway
    Hui Tong et al, 2023, Cellular Signalling CrossRef
13. Long non-coding RNA HOXA-AS3 facilitates the malignancy in colorectal cancer by miR-4319/SPNS2 axis
    Yang Jiang et al, 2021, Journal of Physiology and Biochemistry CrossRef
14. Cutaneous adverse reactions resulting from targeted cancer therapies: histopathologic and clinical findings
    Dylan Haynes et al, 2023, Human Pathology CrossRef
15. AKT Isoforms in the Immune Response in Cancer
    Zayd Ahmad et al, 2022, PI3K and AKT Isoforms in Immunity CrossRef
16. AKT3 is a key regulator of head and neck squamous cell carcinoma
    Hideyuki Takahashi et al, 2021, Cancer Science CrossRef
17. PCDH20 inhibits esophageal squamous cell carcinoma proliferation and migration by suppression of the mitogen-activated protein kinase 9/AKT/β-catenin pathway
    Yijiao Ning et al, 2022, Frontiers in Oncology CrossRef
18. Chemoprevention of 4NQO-Induced Mouse Tongue Carcinogenesis by AKT Inhibitor through the MMP-9/RhoC Signaling Pathway and Autophagy
    Panpan Yin et al, 2022, Analytical Cellular Pathology CrossRef
19. PI3K/Akt/mTOR Signaling Pathway: Role in Esophageal Squamous Cell Carcinoma, Regulatory Mechanisms and Opportunities for Targeted Therapy
    Qian Luo et al, 2022, Frontiers in Oncology CrossRef
20. Overexpression of p-Akt, p-mTOR and p-eIF4E proteins associates with metastasis and unfavorable prognosis in non-small cell lung cancer
    Junmi Lu et al, 2020, PLOS ONE CrossRef
21. Scutellarin Suppresses Patient-Derived Xenograft Tumor Growth by Directly Targeting AKT in Esophageal Squamous Cell Carcinoma
    Feifei Liu et al, 2019, Cancer Prevention Research CrossRef
22. MARCH1 silencing suppresses growth of oral squamous cell carcinoma through regulation of PHLPP2
    L. Liu et al, 2022, Clinical and Translational Oncology CrossRef